ArticleInternational ophthalmology2025
Evaluation of structural and microvascular retinal and choroidal changes using optical coherence tomography angiography in rheumatoid arthritis.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate choroidal and retinal ultrastructural and microvascular changes in patients with rheumatoid arthritis (RA) and their association with RA disease activity.
methodThis case-control study included 32 people with RA and 34 healthy people who were matched in terms of age and sex. Participants underwent retinal and choroidal imaging with swept source optical coherence tomography (SS-OCT) and swept source optical coherence tomography angiography (SS-OCTA). Choroidal thickness (CT), choroidal vascularity index (CVI), foveal avascular zone (FAZ) and vessel density (VD) were calculated and compared between patient and control groups.
resultsSubfoveal choroidal thickness (SFCT) and temporal parafoveal choroidal thickness were significantly thicker in patients than controls (p = 0.028, p = 0.045, p = 0.028, p = 0.010). CVI was significantly lower in patients than controls (p = 0.010). FAZ and VD were not different between control and patient groups (p > 0.05 for all).
conclusionOur study showed increased SFCT and temporal CT, and decreased CVI in RA patients. While no statistically significant difference was found in FAZ and VD values, a trend toward lower VD values was observed in RA patients compared to the control group. Longitudinal evaluation using OCT and OCTA could contribute to elucidating the progression of retinal and choroidal alterations in RA and their potential effect on visual function.
Indexed as
Identifiers
40991061What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.